Hans‐Willi Krell
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 15
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 4
- Oncology top 10%
- Peptidase Inhibition and Analysis 12
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms 4
- Ophthalmology top 5%
-
- Prostate Cancer Treatment and Research 3
-
- Nitric Oxide and Endothelin Effects 2
-
- Effects and risks of endocrine disrupting chemicals 2
-
- Signaling Pathways in Disease 2
Hans‐Willi Krell
22 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 108
- Cancer Research 541
- Immunology and Allergy 137
- Oncology 356
- Hematology 136
- Ophthalmology 89
Countries citing papers authored by Hans‐Willi Krell
This map shows the geographic impact of Hans‐Willi Krell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Willi Krell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Willi Krell more than expected).
Fields of papers citing papers by Hans‐Willi Krell
This network shows the impact of papers produced by Hans‐Willi Krell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Willi Krell. The network helps show where Hans‐Willi Krell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans‐Willi Krell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 24 | |
| 2 | 2006 | 38 | |
| 3 | 2006 | 2 | |
| 4 | 2006 | 21 | |
| 5 | 2005 | 7 | |
| 6 | 2005 | 6 | |
| 7 | 2004 | 141 | |
| 8 | 2004 | 124 | |
| 9 | 2003 | 154 | |
| 10 | 2002 | 62 | |
| 11 | 2002 | 23 | |
| 12 | 2002 | 54 | |
| 13 | 2002 | 16 | |
| 14 | Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. | 2002 | 66 |
| 15 | 2001 | 101 | |
| 16 | 2001 | 122 | |
| 17 | 2001 | 1 | |
| 18 | 2000 | 58 | |
| 19 | 1985 | 4 | |
| 20 | 1984 | 28 |
About Hans‐Willi Krell
Hans‐Willi Krell is a scholar working on Cancer Research, Immunology and Allergy, Oncology, Hematology and Physiology, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (15 papers), Peptidase Inhibition and Analysis (12 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Cell Adhesion Molecules Research (4 papers), Prostate Cancer Treatment and Research (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Signaling Pathways in Disease (2 papers). The work is most often cited by research in Cancer Research (541 citations), Immunology and Allergy (137 citations), Oncology (356 citations), Hematology (136 citations) and Ophthalmology (89 citations). Hans‐Willi Krell has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Frank Grams, Agnès Noël, Erik Maquoi, Françis Frankenne, Jean‐Michel Foidart, Hans Brandstetter, Wolfram Bode, Daniel Lottaz, Christoph Becker and Irene Yiallouros. Their work appears in journals such as Journal of Biological Chemistry, Biological Chemistry, Circulation, Experimental Cell Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.